Please disable your adblock and script blockers to view this page

'New normal:' What should the US strategy be for COVID-19?


JAMA
COVID-19
COVID’
Imperial College London
Medical News
John Hopkins University
MNT
Omicron


JAMA
Katharina Hauck
Arturo Casadevall

No matching tags

No matching tags

No matching tags


the United Kingdom
Baltimore
the United States
U.S.

No matching tags

Positivity     34.00%   
   Negativity   66.00%
The New York Times
SOURCE: http://www.medicalnewstoday.com/articles/new-normal-what-should-the-national-strategy-be-for-covid-19
Write a review: Medical News Today
Summary

A few key uncertainties include:The authors note that “[t]he goal for the ‘new normal’ with COVID-19 does not include eradication or elimination, e.g., the ‘zero COVID’ strategy.” They explain that neither vaccines nor acquiring infection with the virus appear to give anyone lifelong immunity.According to the long-term aspects of SARS-CoV-2, they note that nations need to look at SARS-CoV-2 in relation to the impact of other respiratory viruses. A risk threshold needs to consider three main factors:Considering these factors, the experts recommend several vital elements for public policy and overall health promotion.The authors note that policymakers need to determine their goals in relation to COVID-19 and then communicate them clearly to the public. For example, the authors note adopting strategies to increase vaccinations, collect accurate data, and improve public trust.Focusing more on researching and developing therapeutics to help treat people with COVID-19 is also vital.For instance, Dr. Arturo Casadevall, an infectious disease expert at John Hopkins University in Baltimore, explained to MNT that one of the treatment options some scientists are exploring is convalescent plasma therapy.

As said here by Jessica Norris